JAKKS Pacific Reiterated at Buy and 2 Reiterated Ratings Not to Miss

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on October 1st.

Ariad Pharm (NASDAQ:ARIA): Summer Street Research reiterated its rating of Buy for this company and changed its price target from $21 to $34. Brean Murray reiterated its rating of Buy for this company and changed its price target from $19 to $35.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

JAKKS Pacific (NASDAQ:JAKK): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $20 to $18.

TriQuint Semi (NASDAQ:TQNT): Canaccord Genuity reiterated its rating of Hold for this company and changed its price target from $6 to $5.5.

Don’t Miss: RIM Earnings: Before and After.